OpenAI, Microsoft and Anthropic sign Paris AI safety pact as critics flag weak enforcement
Ten AI firms, including OpenAI and Microsoft, signed the Paris Call for AI Safety and Security, agreeing to new risk-sharing measures. Critics say the agreement lacks enforceable standards. Regulated firms should watch for evolving oversight and compliance expectations.
Dutch regulators investigate Biogen over MS drug market conduct
Dutch authorities are investigating Biogen for possible abuse of dominance in MS treatments and related blood tests. Senior pharma leaders should note the regulatory risk for firms with strong market positions. Watch for further action from Dutch or EU competition authorities.
US Democrats move to probe Trump-era MFN drug pricing agreements
Democratic committee leaders have begun steps to investigate MFN drug pricing agreements from the Trump administration. This could affect pharma pricing strategies and regulatory risk for manufacturers. Policy changes or further scrutiny may follow.
CFTC prepares charges against Kalshi over product notification failures
The CFTC is investigating Kalshi for failing to notify the agency about dozens of new products. This raises compliance risks for financial exchanges using rapid product launches. Senior leaders should review notification processes as regulatory scrutiny increases.
OpenAI and Anthropic must comply with New York’s new AI safety law by 2027
New York’s RAISE Act now requires large AI developers like OpenAI and Anthropic to register and publish safety frameworks. Senior leaders in regulated industries face new compliance and reporting risks as enforcement ramps up. Penalties reach $3 million per violation.
WuXi AppTec removed from US Chinese military company list
WuXi AppTec, a major pharma partner, is no longer on the US list of Chinese military companies. This eases some regulatory and geopolitical risk for pharmaceutical firms working with WuXi. Firms should monitor for further US policy shifts.
Palantir pressed UK minister to expand AI access to NHS GP records, raising data trust issues
Palantir lobbied a UK health minister to include sensitive GP records in its NHS data platform, despite government promises to exclude them. This move raises concerns for healthcare leaders about data privacy, AI governance and patient trust. Watch for government decisions on contract scope and future suppliers.
US AI safety centre moves under White House as experts warn of political risk
The US government’s AI safety division now reports to the White House, according to two former officials. Critics say this could politicise oversight of AI risks, which matter for regulated sectors. Executives should monitor for shifts in AI governance and regulatory approach.
Australia plans criminal law changes and mandatory AI breach reporting after OpenAI incident
Australia will introduce mandatory reporting and consider criminal penalties for AI firms after an OpenAI-linked Medicare data breach. Senior leaders in regulated sectors face stricter oversight for AI risk and incident response. Watch for new AI safety rules and enforcement timelines.
Coinbase gains trust charter from US regulator after two-year process
Coinbase has received an unconditional trust charter from the Office of the Comptroller of the Currency, after applying in October 2025. This move gives the crypto firm a regulatory foothold relevant to banks and payment firms. Senior executives should watch for further regulatory responses.
FDA warns on rare eye risk linked to GLP-1 obesity and diabetes drugs
The FDA has warned that GLP-1 drugs may increase the risk of a rare eye condition. Pharma and biotech leaders face heightened regulatory scrutiny and potential market impact. Companies may need to review safety data and update risk disclosures.
FTC accuses Amazon of ad auction surcharges, raising trust issues for marketers
The FTC alleges Amazon imposed surcharges of up to 250% during major retail events, generating $87 million in extra charges in 2022. This puts transparency and trust in ad tech under scrutiny for marketing leaders. Ongoing legal proceedings may shape future ad buying practices.
Google’s AI visibility changes test UK-mandated search opt-out for publishers
Google has rolled out a global search opt-out for publishers, following a UK regulator’s order, but bundled controls and missing click data complicate decisions. Senior leaders must weigh visibility against control and revenue. Watch for Google’s next move on click data.
AI-generated complaints swamp UK public bodies and employers
UK public bodies and businesses are facing a surge of AI-generated complaints and legal challenges, with employment tribunal claims up 28%. This trend increases operational pressure and legal risk for regulated firms. Leaders may need to review how they handle incoming correspondence.
Anthropic, Google, Microsoft and OpenAI back AI training opt-out token for publishers
Anthropic, Google, Microsoft and OpenAI say they will support a new AI training opt-out policy token. The move gives publishers a standard way to signal if their content can be used for AI training, but enforcement remains weak. Regulated firms face similar data governance issues.
US Justice Department forms Super Intelligence Task Force to target AI crimes
The US Justice Department has set up a Super Intelligence Task Force to lead on AI crimes and lawsuits. This move signals more scrutiny for firms using AI in regulated sectors. Executives should expect new compliance demands and enforcement priorities.
BIO challenges US Medicare pilot linking drug prices to peer nations
BIO is joining a legal challenge to a US Medicare pilot that ties drug prices to those in peer countries. This move could affect how pharma firms set prices in the US. Senior leaders should watch for shifts in pricing policy and legal precedent.
States file new lawsuit to block Trump Medicaid work requirements
States have launched another lawsuit against the Trump administration over Medicaid work requirements, according to STAT. The move signals ongoing legal risk for health insurers and care providers reliant on Medicaid contracts. Watch for further court rulings on implementation.
EU charges TikTok over mental health risks in algorithm-driven feeds
The European Commission has charged TikTok with failing to protect users’ mental health, citing risks from its algorithm-driven content. Digital platforms face growing regulatory pressure to address harms linked to engagement-based business models. Firms should review algorithmic safeguards.
CMS expands power to revoke Medicare billing for owner misconduct
US regulators can now revoke Medicare billing rights from providers and parent firms that breach federal rules. This raises compliance risks for healthcare groups and investors. Boards should review ownership structures and risk controls.